Martin Treder
Fondateur chez LTZ Therapeutics, Inc.
Postes actifs de Martin Treder
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
LTZ Therapeutics, Inc.
 LTZ Therapeutics, Inc. BiotechnologyHealth Technology LTZ Therapeutics, Inc. is an American immunotherapy-focused biotech company that develops novel therapies. The company was founded by Jianhui Zhou, Robert Li, and Martin Treder, with Robert Li serving as the CEO since incorporation. | Directeur Technique/Scientifique/R&D | - | - |
| Fondateur | - | - |
Historique de carrière de Martin Treder
Anciens postes connus de Martin Treder
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AFFIMED N.V. | Directeur Technique/Scientifique/R&D | 01/01/2015 | 22/05/2019 |
CT Atlantic Ltd.
 CT Atlantic Ltd. Miscellaneous Commercial ServicesCommercial Services CT Atlantic AG focuses on the identification and development of human-derived monoclonal antibodies as novel therapeutics for the treatment of cancer. The company was founded by Alexander Knuth, Christoph Esslinger and Edward Stuart in 2008 and is headquartered in Schlieren, Switzerland. | Directeur Technique/Scientifique/R&D | 17/09/2009 | 01/12/2014 |
| Fondateur | 17/09/2009 | 01/12/2014 | |
U3 Pharma AG
 U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany. | Directeur Technique/Scientifique/R&D | 01/01/2002 | 01/01/2002 |
| Fondateur | 01/10/2001 | 01/10/2008 |
Formation de Martin Treder
| Technische Universität München | Doctorate Degree |
| Monash University | Undergraduate Degree |
Statistiques
Internationale
| Allemagne | 4 |
| Suisse | 2 |
| Australie | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
| Doctorate Degree | 1 |
Sectorielle
| Commercial Services | 3 |
| Consumer Services | 3 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AFFIMED N.V. | Health Technology |
| Entreprise privées | 3 |
|---|---|
CT Atlantic Ltd.
CT Atlantic Ltd. Miscellaneous Commercial ServicesCommercial Services CT Atlantic AG focuses on the identification and development of human-derived monoclonal antibodies as novel therapeutics for the treatment of cancer. The company was founded by Alexander Knuth, Christoph Esslinger and Edward Stuart in 2008 and is headquartered in Schlieren, Switzerland. | Commercial Services |
U3 Pharma AG
U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany. | Commercial Services |
LTZ Therapeutics, Inc.
LTZ Therapeutics, Inc. BiotechnologyHealth Technology LTZ Therapeutics, Inc. is an American immunotherapy-focused biotech company that develops novel therapies. The company was founded by Jianhui Zhou, Robert Li, and Martin Treder, with Robert Li serving as the CEO since incorporation. | Health Technology |
- Bourse
- Insiders
- Martin Treder
- Expérience
